Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under ...

Sonidegib phosphate is under clinical development by Sun Pharma Advanced Research and currently in Phase I for Hepatocellular Carcinoma.

Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.

In the same year, Sun Pharma opened its first manufacturing facility for the production of tablets and capsules at Vapi, Gujarat, India. Initially, the company manufactured five psychiatry products.

The Narcotics Control Bureau (NCB) in Mumbai seized 74,000 capsules (29.6 kgs) of illicitly diverted pharmaceutical drugs and 244,400 cigarettes in a preventive ...

Similarly, India’s leading drug maker Sun Pharmaceutical Industries got approval in India for Etifoxine Hydrochloride capsules, used in treating anxiety-related disorders excessive worry, tension, and ...

In the US, the product launched with a wholesale acquisition cost (WAC) of $3,950 per 60 capsules – enough ... a patent challenge from India's Sun Pharmaceuticals relating to a dosing protocol ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.61% to 1,826.10 Indian rupees Thursday, on what proved to ...

Sun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares ...

Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...

Dharmesh’s top picks include: -Aurobindo Pharma -Sun Pharma -AstraZeneca Pharma India Will Pharma and Healthcare stocks continue to outperform in 2025? Watch the full video for detailed insights ...